3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Infectious Mononucleosis
1
Epstein-Barr Virus Infections
1
Interventions
valomaciclovir
1
Valacyclovir
1
Rituximab
1
Procalcitonin
1
Brentuximab Vedotin
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Infectious Mononucleosis
×
valomaciclovir
×
Clear all
NCT00575185
2017-03-22
Mono6
University of Minnesota
Phase 1/2
Completed
23 enrolled
8 charts